Page last updated: 2024-10-29

ketamine and Asthma

ketamine has been researched along with Asthma in 47 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research Excerpts

ExcerptRelevanceReference
"We determine whether a continuous infusion of ketamine can decrease the severity of a moderately severe acute asthma exacerbation by a clinically significant 2 points using a 15-point Pulmonary Index scoring scale."9.11The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. ( Allen, JY; Macias, CG, 2005)
"IV ketamine at a dose low enough to avoid dysphoric reactions demonstrated no increased bronchodilatory effect compared with standard therapy in treating exacerbations of asthma in the ED."9.08Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. ( Duffy, S; Howton, JC; Levitt, MA; Rose, J; Zoltanski, T, 1996)
"The single study on non-intubated children with severe acute asthma did not show significant benefit and does not support the case studies and observational reports showing benefits of ketamine in both non-ventilated and ventilated children."8.88Ketamine for management of acute exacerbations of asthma in children. ( Chawla, D; Jat, KR, 2012)
"To evaluate the role of ketamine in management of severe exacerbation of asthma in adults."8.81Does ketamine have a role in managing severe exacerbation of asthma in adults? ( Lau, TT; Zed, PJ, 2001)
"We present the case of a young female with a history of allergies to medicines, specifically to benzodiazepines, who presented bronchospasm and oxygen saturation drop after receiving a dose of midazolam into her eye while she was working."8.12[Ketamine as a treatment of bronchospasm due to an anaphylaxis. A case report]. ( Ávila-García, JE; Calleja-Alarcón, S; Guerrero-Escobar, JC; Romero-Gutiérrez, L; Sánchez-Hurtado, LA, 2022)
"The study concluded that ketamine reduced oxidative stress and attenuated asthmatic symptoms (neutrophilic airway inflammation) by activating the Nrf2-Keap1 pathway, with 75 mg/kg ketamine showing the best results."8.12Ketamine Attenuates Airway Inflammation via Inducing Inflammatory Cells Apoptosis and Activating Nrf2 Pathway in a Mixed-Granulocytic Murine Asthma Model. ( Wang, Q; Xiao, S; Yang, D; Zhou, Y, 2022)
"In this study, ketamine use was not associated with improvement in ventilatory variables associated with bronchospasm."7.96Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial. ( Costa, R; Marin, L; Marques, L; Mendez, G; Nedel, W; Vargas, T, 2020)
"This case suggests that intravenous ketamine given in a dissociative dose may be an effective temporizing measure to avoid mechanical ventilation in adult patients with severe asthma exacerbations."7.77Intravenous ketamine in a dissociating dose as a temporizing measure to avoid mechanical ventilation in adult patient with severe asthma exacerbation. ( Hawthorne, T; Shlamovitz, GZ, 2011)
"A 75-year-old male diagnosed to be a case of intractable asthma resistant to all conventional therapies requiring ventilatory support, was successfully weaned off the ventilator after treatment with subanaesthetic dose of intravenous ketamine."7.77Subanaesthetic dose of ketamine in intractable asthma. ( Garg, D; Kaistha, S; Sood, D, 2011)
" In the present results, ayanin did not affect xylazine/ketamine-induced anesthesia, suggesting that ayanin has few or no adverse effects, such as nausea, vomiting, and gastric hypersecretion."7.76Ayanin, a non-selective phosphodiesterase 1-4 inhibitor, effectively suppresses ovalbumin-induced airway hyperresponsiveness without affecting xylazine/ketamine-induced anesthesia. ( Chen, CM; Ko, WC; Lee, FP; Shen, HY; Shih, CM, 2010)
"Both inhalation and systemic administration of ketamine attenuate inflammatory the lung injury and airway hyperreactivity of the OVA-induced asthma model."7.74[Protective effects of ketamine on allergen-induced airway inflammatory injure and high airway reactivity in asthma: experiment with rats]. ( Ding, ZN; Fu, CZ; Qian, YN; Rong, HB; Xu, YM; Zhu, MM; Zhu, W, 2007)
" Anesthesia was induced with propofol and ketamine under the Sellick maneuver."7.70[Bronchospasm during crush induction with propofol under the Sellick maneuver in a patient for emergency laparotomy]. ( Doi, K; Saito, Y; Sato, K; Yamada, Y; Yamamori, Y, 1999)
"Two patients with acute severe asthma, who failed to respond to conventional therapy, were given intravenous ketamine in sub-anaesthetic doses with good results."7.68Use of ketamine in acute severe asthma. ( Sarma, VJ, 1992)
"In vitro preparations of trachea isolated from normal and asthmatic guinea pigs were used to measure their maximum contractile response to histamine challenge and to determine spontaneous relaxation of smooth muscle of the airway."7.66Effects of ketamine and halothane on normal and asthmatic smooth muscle of the airway in guinea pigs. ( Aldrete, JA; Cabanas, A; Souhrada, JF, 1980)
" We found a large heterogeneity regarding sample size, age and gender distribution, inclusion criteria (different severity scores, if any) and ketamine dosing (bolus and/or continuous infusion)."6.82Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies. ( Astuto, M; Brancati, S; Crimi, C; Cuttone, G; Dezio, V; Falcone, M; La Via, L; Sanfilippo, F, 2022)
"Ketamine was introduced into clinical anaesthesia in 1965."6.38[Ketamine as a broncholytic agent in status asthmaticus and as an anesthetic for patients with bronchial asthma]. ( Jørgensen, BG, 1992)
"Ketamine appears to increase catecholamine levels and directly relax bronchial smooth muscle."5.27Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. ( L'Hommedieu, CS; Reyes de la Rocha, S; Rock, MJ; Truemper, E, 1986)
"Ketamine is a useful drug in the intensive treatment of status asthmaticus and should be tried before a decision is taken to start mechanical ventilation."5.27Ketamine by continuous infusion in status asthmaticus. ( Hallam, PL; Strube, PJ, 1986)
"Ketamine was given IV with a rapid fall in pCO2."5.27The use of ketamine for the emergency intubation of patients with status asthmaticus. ( Arens, JJ; L'Hommedieu, CS, 1987)
"We determine whether a continuous infusion of ketamine can decrease the severity of a moderately severe acute asthma exacerbation by a clinically significant 2 points using a 15-point Pulmonary Index scoring scale."5.11The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. ( Allen, JY; Macias, CG, 2005)
"IV ketamine at a dose low enough to avoid dysphoric reactions demonstrated no increased bronchodilatory effect compared with standard therapy in treating exacerbations of asthma in the ED."5.08Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. ( Duffy, S; Howton, JC; Levitt, MA; Rose, J; Zoltanski, T, 1996)
"The single study on non-intubated children with severe acute asthma did not show significant benefit and does not support the case studies and observational reports showing benefits of ketamine in both non-ventilated and ventilated children."4.88Ketamine for management of acute exacerbations of asthma in children. ( Chawla, D; Jat, KR, 2012)
"To evaluate the role of ketamine in management of severe exacerbation of asthma in adults."4.81Does ketamine have a role in managing severe exacerbation of asthma in adults? ( Lau, TT; Zed, PJ, 2001)
"The study concluded that ketamine reduced oxidative stress and attenuated asthmatic symptoms (neutrophilic airway inflammation) by activating the Nrf2-Keap1 pathway, with 75 mg/kg ketamine showing the best results."4.12Ketamine Attenuates Airway Inflammation via Inducing Inflammatory Cells Apoptosis and Activating Nrf2 Pathway in a Mixed-Granulocytic Murine Asthma Model. ( Wang, Q; Xiao, S; Yang, D; Zhou, Y, 2022)
"We present the case of a young female with a history of allergies to medicines, specifically to benzodiazepines, who presented bronchospasm and oxygen saturation drop after receiving a dose of midazolam into her eye while she was working."4.12[Ketamine as a treatment of bronchospasm due to an anaphylaxis. A case report]. ( Ávila-García, JE; Calleja-Alarcón, S; Guerrero-Escobar, JC; Romero-Gutiérrez, L; Sánchez-Hurtado, LA, 2022)
"In this study, ketamine use was not associated with improvement in ventilatory variables associated with bronchospasm."3.96Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial. ( Costa, R; Marin, L; Marques, L; Mendez, G; Nedel, W; Vargas, T, 2020)
"A 75-year-old male diagnosed to be a case of intractable asthma resistant to all conventional therapies requiring ventilatory support, was successfully weaned off the ventilator after treatment with subanaesthetic dose of intravenous ketamine."3.77Subanaesthetic dose of ketamine in intractable asthma. ( Garg, D; Kaistha, S; Sood, D, 2011)
"This case suggests that intravenous ketamine given in a dissociative dose may be an effective temporizing measure to avoid mechanical ventilation in adult patients with severe asthma exacerbations."3.77Intravenous ketamine in a dissociating dose as a temporizing measure to avoid mechanical ventilation in adult patient with severe asthma exacerbation. ( Hawthorne, T; Shlamovitz, GZ, 2011)
" In the present results, ayanin did not affect xylazine/ketamine-induced anesthesia, suggesting that ayanin has few or no adverse effects, such as nausea, vomiting, and gastric hypersecretion."3.76Ayanin, a non-selective phosphodiesterase 1-4 inhibitor, effectively suppresses ovalbumin-induced airway hyperresponsiveness without affecting xylazine/ketamine-induced anesthesia. ( Chen, CM; Ko, WC; Lee, FP; Shen, HY; Shih, CM, 2010)
"Both inhalation and systemic administration of ketamine attenuate inflammatory the lung injury and airway hyperreactivity of the OVA-induced asthma model."3.74[Protective effects of ketamine on allergen-induced airway inflammatory injure and high airway reactivity in asthma: experiment with rats]. ( Ding, ZN; Fu, CZ; Qian, YN; Rong, HB; Xu, YM; Zhu, MM; Zhu, W, 2007)
" Anesthesia was induced with propofol and ketamine under the Sellick maneuver."3.70[Bronchospasm during crush induction with propofol under the Sellick maneuver in a patient for emergency laparotomy]. ( Doi, K; Saito, Y; Sato, K; Yamada, Y; Yamamori, Y, 1999)
"This paper presents preliminary estimation of clinical usefulness of isoflurane for treatment of severe cases of status asthmaticus in children and application of it as monoanesthesia in children with bronchial asthma, operated upon sudden indications."3.69[Use of inhalation anesthetics in treatment of severe status asthmaticus and for anesthesia in children suffering from bronchial asthma. Preliminary report]. ( Bujok, G; Kudła, M; Sada-Cieślar, M, 1995)
"Two patients with acute severe asthma, who failed to respond to conventional therapy, were given intravenous ketamine in sub-anaesthetic doses with good results."3.68Use of ketamine in acute severe asthma. ( Sarma, VJ, 1992)
"In vitro preparations of trachea isolated from normal and asthmatic guinea pigs were used to measure their maximum contractile response to histamine challenge and to determine spontaneous relaxation of smooth muscle of the airway."3.66Effects of ketamine and halothane on normal and asthmatic smooth muscle of the airway in guinea pigs. ( Aldrete, JA; Cabanas, A; Souhrada, JF, 1980)
" We found a large heterogeneity regarding sample size, age and gender distribution, inclusion criteria (different severity scores, if any) and ketamine dosing (bolus and/or continuous infusion)."2.82Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies. ( Astuto, M; Brancati, S; Crimi, C; Cuttone, G; Dezio, V; Falcone, M; La Via, L; Sanfilippo, F, 2022)
" After long-term use as a dissociative anesthetic, it has re-emerged as a useful agent for ameliorating pain, asthmaticus, and depression."2.50Ketamine-an update on its clinical uses and abuses. ( Lei, H; Xu, J, 2014)
"Ketamine was introduced into clinical anaesthesia in 1965."2.38[Ketamine as a broncholytic agent in status asthmaticus and as an anesthetic for patients with bronchial asthma]. ( Jørgensen, BG, 1992)
"Ketamine was given IV with a rapid fall in pCO2."1.27The use of ketamine for the emergency intubation of patients with status asthmaticus. ( Arens, JJ; L'Hommedieu, CS, 1987)
"Ketamine appears to increase catecholamine levels and directly relax bronchial smooth muscle."1.27Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. ( L'Hommedieu, CS; Reyes de la Rocha, S; Rock, MJ; Truemper, E, 1986)
"Ketamine is a useful drug in the intensive treatment of status asthmaticus and should be tried before a decision is taken to start mechanical ventilation."1.27Ketamine by continuous infusion in status asthmaticus. ( Hallam, PL; Strube, PJ, 1986)

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-199011 (23.40)18.7374
1990's12 (25.53)18.2507
2000's7 (14.89)29.6817
2010's12 (25.53)24.3611
2020's5 (10.64)2.80

Authors

AuthorsStudies
Garner, O1
Ramey, JS1
Hanania, NA1
Calleja-Alarcón, S1
Sánchez-Hurtado, LA1
Romero-Gutiérrez, L1
Guerrero-Escobar, JC1
Ávila-García, JE1
La Via, L1
Sanfilippo, F1
Cuttone, G1
Dezio, V1
Falcone, M1
Brancati, S1
Crimi, C1
Astuto, M1
Xiao, S1
Zhou, Y4
Wang, Q3
Yang, D2
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J6
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J3
Sun, Q1
Han, D1
Lei, H2
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y5
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C2
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM2
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X3
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Xue, H1
Zhang, W1
Ruan, Z1
Li, S3
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y3
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Nedel, W1
Costa, R1
Mendez, G1
Marin, L1
Vargas, T1
Marques, L1
Elkoundi, A1
Bentalha, A1
El Koraichi, A1
El Kettani, SE1
Zou, H1
Wang, LX1
Wang, M1
Cheng, C1
Shen, Q1
Fang, L1
Liu, R1
Jones, BP1
Paul, A1
Maddox, RP1
Seupaul, RA1
Stemp, LI1
Song, L1
Sen, S1
Zhou, J1
Mo, L1
Shlamovitz, GZ1
Hawthorne, T1
Lee, FP1
Shih, CM1
Shen, HY1
Chen, CM2
Ko, WC1
Garg, D1
Kaistha, S1
Sood, D1
Jat, KR1
Chawla, D1
Chugh, K1
Govindarajan, R1
Chaudhry, R1
Babalola, O1
Nguyen, N1
Michael, R1
Sultan, S1
Allen, JY1
Macias, CG1
Bratton, SL1
Odetola, FO1
McCollegan, J1
Cabana, MD1
Levy, FH1
Keenan, HT1
Denmark, TK1
Crane, HA1
Brown, L1
Zhu, MM1
Qian, YN1
Zhu, W1
Rong, HB1
Ding, ZN1
Fu, CZ1
Chen, BL1
Cabanas, A1
Souhrada, JF1
Aldrete, JA1
Sada-Cieślar, M1
Bujok, G1
Kudła, M1
Marai, W1
Jahangir, SM2
Islam, F2
Chowdhury, SN1
Aziz, L2
Ghani, MA1
Achar, MN1
Achar, KN1
Howton, JC1
Rose, J1
Duffy, S1
Zoltanski, T1
Levitt, MA1
Nehama, J1
Pass, R1
Bechtler-Karsch, A1
Steinberg, C1
Notterman, DA1
Feddersen, CO1
Yamada, Y1
Doi, K1
Sato, K1
Yamamori, Y1
Saito, Y1
Ishihara, H1
Lau, TT1
Zed, PJ1
Hirshman, CA1
Downes, H1
Farbood, A1
Bergman, NA1
Nastri, D1
Amatruda, G1
Di Vito, A1
Jørgensen, BG1
Sarma, VJ1
Robinson, PN1
Gram-Hansen, P1
Klausen, NO1
Boysen, K1
Strøm, JJ1
Eskildsen, PC1
L'Hommedieu, CS2
Arens, JJ1
Rock, MJ1
Reyes de la Rocha, S1
Truemper, E1
Strube, PJ1
Hallam, PL1
Huber, FC1
Gutierrez, J1
Corssen, G1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Ketamine Efficacy for Acute Severe Bronchospasm in Mechanically Ventilated-critically Ill Patients: a Randomized Controlled Trial[NCT03000413]Phase 2/Phase 390 participants (Anticipated)Interventional2015-08-31Recruiting
Efficacy and Safety of Continuous Infusion of Ketamine in Pediatric Intensive Care Unit (KISS Study)[NCT04427605]57 participants (Actual)Observational2019-04-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

11 reviews available for ketamine and Asthma

ArticleYear
Management of Life-Threatening Asthma: Severe Asthma Series.
    Chest, 2022, Volume: 162, Issue:4

    Topics: Adrenal Cortex Hormones; Asthma; Humans; Ketamine; Magnesium Sulfate; Muscarinic Antagonists; Propof

2022
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:10

    Topics: Adrenal Cortex Hormones; Adult; Aminophylline; Anti-Asthmatic Agents; Asthma; Child; Cholinergic Ant

2022
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Management of acute asthma in the pediatric patient: an evidence-based review.
    Pediatric emergency medicine practice, 2013, Volume: 10, Issue:5

    Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anesthetics, Dissociative; Asthma; Blood Gas Anal

2013
Ketamine-an update on its clinical uses and abuses.
    CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:12

    Topics: Analgesics; Animals; Asthma; Depressive Disorder, Major; Gastrointestinal Tract; Humans; Ketamine; P

2014
Ketamine for management of acute exacerbations of asthma in children.
    The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11

    Topics: Acute Disease; Adolescent; Asthma; Bronchodilator Agents; Child; Child, Preschool; Disease Progressi

2012
Acute asthma in emergency room.
    Indian journal of pediatrics, 2003, Volume: 70 Suppl 1

    Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Aminophyl

2003
Continuous ketamine infusion for the treatment of refractory asthma in a mechanically ventilated infant: case report and review of the pediatric literature.
    Pediatric emergency care, 1996, Volume: 12, Issue:4

    Topics: Adolescent; Anesthetics, Dissociative; Asthma; Child; Child, Preschool; Combined Modality Therapy; H

1996
[Applicability of intravenous anesthesia--special reference to propofol and ketamine].
    Masui. The Japanese journal of anesthesiology, 1999, Volume: 48 Suppl

    Topics: Anesthesia, Intravenous; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Intravenou

1999
Does ketamine have a role in managing severe exacerbation of asthma in adults?
    Pharmacotherapy, 2001, Volume: 21, Issue:9

    Topics: Adult; Asthma; Excitatory Amino Acid Antagonists; Humans; Ketamine; Randomized Controlled Trials as

2001
[Ketamine as a broncholytic agent in status asthmaticus and as an anesthetic for patients with bronchial asthma].
    Ugeskrift for laeger, 1992, Jul-27, Volume: 154, Issue:31

    Topics: Animals; Asthma; Bronchodilator Agents; Humans; Ketamine; Lung; Status Asthmaticus

1992

Trials

3 trials available for ketamine and Asthma

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma.
    Annals of emergency medicine, 2005, Volume: 46, Issue:1

    Topics: Adolescent; Anesthetics, Dissociative; Asthma; Bronchodilator Agents; Child; Child, Preschool; Doubl

2005
The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma.
    Annals of emergency medicine, 2005, Volume: 46, Issue:1

    Topics: Adolescent; Anesthetics, Dissociative; Asthma; Bronchodilator Agents; Child; Child, Preschool; Doubl

2005
The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma.
    Annals of emergency medicine, 2005, Volume: 46, Issue:1

    Topics: Adolescent; Anesthetics, Dissociative; Asthma; Bronchodilator Agents; Child; Child, Preschool; Doubl

2005
The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma.
    Annals of emergency medicine, 2005, Volume: 46, Issue:1

    Topics: Adolescent; Anesthetics, Dissociative; Asthma; Bronchodilator Agents; Child; Child, Preschool; Doubl

2005
Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma.
    Annals of emergency medicine, 1996, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Anesthetics, Dissociative; Asthma; Bronchodilator Age

1996

Other Studies

34 other studies available for ketamine and Asthma

ArticleYear
[Ketamine as a treatment of bronchospasm due to an anaphylaxis. A case report].
    Revista medica del Instituto Mexicano del Seguro Social, 2022, May-02, Volume: 60, Issue:3

    Topics: Anaphylaxis; Asthma; Bronchial Spasm; Female; Humans; Ketamine; Midazolam

2022
Ketamine Attenuates Airway Inflammation via Inducing Inflammatory Cells Apoptosis and Activating Nrf2 Pathway in a Mixed-Granulocytic Murine Asthma Model.
    Drug design, development and therapy, 2022, Volume: 16

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Inflammation; Kelch-Like ECH-

2022
Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial.
    Anaesthesiology intensive therapy, 2020, Volume: 52, Issue:3

    Topics: Aged; Airway Resistance; Analgesics, Opioid; Anesthetics, Dissociative; Asthma; Bronchial Spasm; Bro

2020
Nebulized ketamine to avoid mechanical ventilation in a pediatric patient with severe asthma exacerbation.
    The American journal of emergency medicine, 2018, Volume: 36, Issue:4

    Topics: Asthma; Bronchodilator Agents; Child, Preschool; Disease Progression; Emergency Service, Hospital; F

2018
MTOR-Mediated Autophagy Is Involved in the Protective Effect of Ketamine on Allergic Airway Inflammation.
    Journal of immunology research, 2019, Volume: 2019

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Autophagy; Bronchoalveolar Lavage Fluid; Cytokines; Disea

2019
Is ketamine effective for the management of acute asthma exacerbations in children?
    Annals of emergency medicine, 2014, Volume: 63, Issue:3

    Topics: Asthma; Bronchodilator Agents; Humans; Ketamine

2014
Ketamine for status asthmaticus with respiratory failure.
    The Journal of emergency medicine, 2014, Volume: 47, Issue:5

    Topics: Anesthetics, Dissociative; Asthma; Female; Humans; Ketamine

2014
Ketamine Inhalation Ameliorates Ovalbumin-Induced Murine Asthma by Suppressing the Epithelial-Mesenchymal Transition.
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Jul-15, Volume: 22

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Epi

2016
Intravenous ketamine in a dissociating dose as a temporizing measure to avoid mechanical ventilation in adult patient with severe asthma exacerbation.
    The Journal of emergency medicine, 2011, Volume: 41, Issue:5

    Topics: Adult; Anesthesia, Intravenous; Anesthetics, Dissociative; Asthma; Disease Progression; Female; Huma

2011
Ayanin, a non-selective phosphodiesterase 1-4 inhibitor, effectively suppresses ovalbumin-induced airway hyperresponsiveness without affecting xylazine/ketamine-induced anesthesia.
    European journal of pharmacology, 2010, Jun-10, Volume: 635, Issue:1-3

    Topics: Anesthesia; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Female; Flavonoids; Hypersensi

2010
Subanaesthetic dose of ketamine in intractable asthma.
    Journal of the Indian Medical Association, 2011, Volume: 109, Issue:6

    Topics: Aged; Anesthetics, Dissociative; Asthma; Bronchial Spasm; Drug Repositioning; Drug Resistance, Multi

2011
Airway management in acute respiratory distress secondary to tracheal stenosis following one time intubation.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2004, Volume: 51, Issue:4

    Topics: Adolescent; Analgesics; Anesthesia, Inhalation; Anesthetics, Local; Asthma; Emergency Treatment; Fib

2004
Regional variation in ICU care for pediatric patients with asthma.
    The Journal of pediatrics, 2005, Volume: 147, Issue:3

    Topics: Anti-Asthmatic Agents; Asthma; Child; Cohort Studies; Critical Care; Excitatory Amino Acid Antagonis

2005
Ketamine to avoid mechanical ventilation in severe pediatric asthma.
    The Journal of emergency medicine, 2006, Volume: 30, Issue:2

    Topics: Anesthetics, Dissociative; Asthma; Child; Child, Preschool; Humans; Infusions, Intravenous; Ketamine

2006
[Protective effects of ketamine on allergen-induced airway inflammatory injure and high airway reactivity in asthma: experiment with rats].
    Zhonghua yi xue za zhi, 2007, May-22, Volume: 87, Issue:19

    Topics: Airway Resistance; Allergens; Animals; Asthma; Blotting, Western; Bronchial Hyperreactivity; Bronchi

2007
[Postoperative asthmaticus status controlled with ketamine (author's transl)].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1981, Volume: 19, Issue:4

    Topics: Asthma; Humans; Ketamine; Male; Middle Aged; Postoperative Complications

1981
Effects of ketamine and halothane on normal and asthmatic smooth muscle of the airway in guinea pigs.
    Canadian Anaesthetists' Society journal, 1980, Volume: 27, Issue:1

    Topics: Anaphylaxis; Animals; Asthma; Dose-Response Relationship, Drug; Drug Interactions; Guinea Pigs; Halo

1980
[Use of inhalation anesthetics in treatment of severe status asthmaticus and for anesthesia in children suffering from bronchial asthma. Preliminary report].
    Pneumonologia i alergologia polska, 1995, Volume: 63, Issue:3-4

    Topics: Administration, Inhalation; Adolescent; Anesthesia, Inhalation; Asthma; Bronchi; Child; Child, Presc

1995
Exaggerated psychomotor response to intravenous bolus dose administration of ketamine.
    Ethiopian medical journal, 1994, Volume: 32, Issue:2

    Topics: Adult; Akathisia, Drug-Induced; Asthma; Female; Humans; Injections, Intravenous; Ketamine; Uterine H

1994
Ketamine infusion for postoperative analgesia: a prospective cohort study in asthmatics.
    Bangladesh Medical Research Council bulletin, 1993, Volume: 19, Issue:1

    Topics: Adult; Analgesia; Asthma; Cohort Studies; Diazepam; Female; Humans; Infusions, Intravenous; Ketamine

1993
Ketamine infusion for postoperative analgesia in asthmatics: a comparison with intermittent meperidine.
    Anesthesia and analgesia, 1993, Volume: 76, Issue:1

    Topics: Adult; Asthma; Bronchial Spasm; Female; Humans; Hysterectomy; Infusions, Intravenous; Ketamine; Mepe

1993
Efficacy of ketamine infusion in refractory asthma complicated by acute myocardial infarction.
    Anaesthesia and intensive care, 1993, Volume: 21, Issue:1

    Topics: Asthma; Bronchial Spasm; Conscious Sedation; Female; Humans; Infusions, Intravenous; Ketamine; Midaz

1993
[Ketanest in bronchial asthma].
    Der Internist, 1998, Volume: 39, Issue:9

    Topics: Anesthetics, Dissociative; Asthma; Drug Therapy, Combination; Humans; Ketamine; Status Asthmaticus

1998
[Bronchospasm during crush induction with propofol under the Sellick maneuver in a patient for emergency laparotomy].
    Masui. The Japanese journal of anesthesiology, 1999, Volume: 48, Issue:11

    Topics: Anesthesia; Asthma; Bronchial Spasm; Emergencies; Humans; Intestinal Obstruction; Intubation, Intrat

1999
Ketamine block of bronchospasm in experimental canine asthma.
    British journal of anaesthesia, 1979, Volume: 51, Issue:8

    Topics: Airway Resistance; Anesthesia, Intravenous; Animals; Antigens; Ascaris; Asthma; Bronchial Spasm; Dis

1979
[Physio-pathological considerations and clinical contribution on the use of ketamine-pancuronium combination in the anesthesia of an asthmatic patient].
    Minerva anestesiologica, 1975, Volume: 41, Issue:9

    Topics: Adolescent; Adult; Aged; Anesthesia, General; Asthma; Child; Drug Synergism; Female; Humans; Ketamin

1975
Use of ketamine in acute severe asthma.
    Acta anaesthesiologica Scandinavica, 1992, Volume: 36, Issue:1

    Topics: Adult; Asthma; Bronchial Spasm; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Ket

1992
Ketamine in acute asthma.
    Lancet (London, England), 1985, Mar-09, Volume: 1, Issue:8428

    Topics: Acute Disease; Asthma; Humans; Ketamine

1985
[Ketamine in the treatment of severe therapy-resistant status asthmaticus].
    Ugeskrift for laeger, 1988, Feb-22, Volume: 150, Issue:8

    Topics: Asthma; Child; Female; Humans; Infant; Ketamine; Status Asthmaticus

1988
[Status asthmaticus treated with ketamine].
    Ugeskrift for laeger, 1987, Jul-20, Volume: 149, Issue:30

    Topics: Asthma; Humans; Ketamine; Male; Middle Aged; Status Asthmaticus

1987
The use of ketamine for the emergency intubation of patients with status asthmaticus.
    Annals of emergency medicine, 1987, Volume: 16, Issue:5

    Topics: Asthma; Emergencies; Female; Hemodynamics; Humans; Infant; Intubation, Intratracheal; Ketamine; Kine

1987
Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy.
    Critical care medicine, 1986, Volume: 14, Issue:5

    Topics: Acute Disease; Adolescent; Asthma; Child; Child, Preschool; Combined Modality Therapy; Drug Therapy,

1986
Ketamine by continuous infusion in status asthmaticus.
    Anaesthesia, 1986, Volume: 41, Issue:10

    Topics: Adolescent; Asthma; Critical Care; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous;

1986
Ketamine: its effect on airway resistance in man.
    Southern medical journal, 1972, Volume: 65, Issue:10

    Topics: Airway Resistance; Anesthesia, General; Asthma; Bronchial Spasm; Humans; Ketamine; Lung Compliance

1972